The
endochin-like quinolone (ELQ) compound class may yield effective,
safe treatments for a range of important human and animal afflictions.
However, to access the public health potential of this compound series,
a synthetic route needed to be devised, which would lower costs and
be amenable to large-scale production. In the new synthetic route
described here, a substituted β-keto ester, formed by an Ullmann
reaction and subsequent acylation, is reacted with an aniline via
a Conrad–Limpach reaction to produce 3-substituted 4(1H)-quinolones such as ELQ-300 and ELQ-316. This synthetic route, the first described to be truly amenable
to industrial-scale production, is relatively short (five reaction
steps), does not require palladium, chromatographic separation, or
protecting group chemistry, and may be performed without high vacuum
distillation.